Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR
Latest Information Update: 16 Jul 2020
At a glance
- Drugs Atorvastatin/metformin (Primary) ; Atorvastatin; Metformin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 28 Dec 2016 Status changed from not yet recruiting to completed.
- 14 Jul 2014 New trial record